Hunan Nucien Pharmaceutical Co Ltd
688189
Company Profile
Business description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
Contact
No. 1 Kangli Road
Liuyang Economic and Technological Development Zone
Hunan Province
Changsha510100
CHNSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
302
Stocks News & Analysis
stocks
Our view after CBA shares plunge
Steady profit, but rising risks and rich valuation give pause.
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
Amid robust demand for semis, watch for any impact of in-house built chips and whether the supply chain is on track.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,884.70 | 18.30 | 0.21% |
| CAC 40 | 8,032.84 | 24.87 | 0.31% |
| DAX 40 | 24,339.39 | 202.58 | 0.84% |
| Dow JONES (US) | 49,693.20 | 67.36 | -0.14% |
| FTSE 100 | 10,321.58 | 3.77 | -0.04% |
| HKSE | 26,367.88 | 20.56 | -0.08% |
| NASDAQ | 26,402.34 | 314.14 | 1.20% |
| Nikkei 225 | 62,654.05 | 618.06 | -0.98% |
| NZX 50 Index | 13,025.07 | 37.99 | -0.29% |
| S&P 500 | 7,444.25 | 43.29 | 0.58% |
| S&P/ASX 200 | 8,640.70 | 26.00 | 0.30% |
| SSE Composite Index | 4,177.92 | 64.65 | -1.52% |